期刊文献+

鹤蟾片诱导人肺腺癌A549细胞凋亡的实验研究 被引量:7

Apoptosis Inducing Effect of Hechanpian on Human Lung Adenocarcinoma A549 Cells
下载PDF
导出
摘要 目的研究鹤蟾片对A549人肺腺癌细胞凋亡的影响。方法制备大鼠含药血清,MTT法检测鹤蟾片含药血清对A549细胞的生长抑制率。利用PI染色观察和流式细胞术研究该含药血清对A549细胞凋亡的影响。RT-PCR检测含药血清对细胞表皮生长因子受体(epidermal growth factor receptor,EGFR)mRNA表达的调节作用。结果鹤蟾片含药血清明显抑制A549细胞生长,并使该细胞呈凋亡形态学改变。10%、20%含药血清组的细胞凋亡率为20.5%、33.2%,与对照组(6.1%)比较,差异均有统计学意义(P<0.05)。含药血清组的细胞EGFR表达明显低于对照组(P<0.05)。结论鹤蟾片具有诱导人肺腺癌A549细胞凋亡的作用,分子机制可能与抑制EGFR基因的转录有关。 Objective To study the apoptosis inducing effects of Hechanpian (HCP) on human lung adenocarcinoma A549 cells. Methods HCP containing rat serum was prepared and applied on A549 cells. The cell growth inhibition rate was tested by MTT assay; the effect of HCP on cell apoptosis was observed with Propidium iodide (PI) staining and flow cytometry analysis; the mRNA expression of epidermal growth factor receptor (EGFR) was detected through RT-PCR.Results The growth of A549 cells was obviously inhibited after being treated by HCP containing serum,and the cells presented an apoptotic change. The cell apoptosis rate after treated by serum containing 10% and 20% HCP was 20.5% and 33.2%,respectively,significantly higher than that in the control (6.1% in cells didn't treated with HCP,P0.05). Compared with control,EGFR mRNA expression in HCP treated cells was significantly lower (P0.05).Conclusion HCP has apoptosis inducing effect on A549 cell,and its molecular mechanism is probably correlated with the inhibition of EGFR gene transcription.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2010年第6期607-610,共4页 Chinese Journal of Integrated Traditional and Western Medicine
基金 高等学校博士学科点专项科研基金资助(No.2009442512008) 中国博士后科学基金资助(No.20090450854)
关键词 鹤蟾片 肺癌 细胞凋亡 Hechanpian lung cancer cell apoptosis
  • 相关文献

参考文献9

  • 1陆真权,陈焕伟.鹤蟾片合盖诺、顺铂治疗晚期非小细胞肺癌的研究[J].现代中西医结合杂志,2006,15(13):1730-1731. 被引量:4
  • 2周岱翰,林丽珠,周宜强,罗荣城,刘魁凤,贾英杰,陈继跃,牛喜伟,苏碧茹,韩慧,鲁江,张恩欣,王树堂.中西医结合治疗非小细胞肺癌近期疗效观察[J].中国中西医结合杂志,2005,25(12):1061-1065. 被引量:52
  • 3周岱翰,林丽珠,周宜强,罗荣城,刘魁凤,贾英杰,陈继跃,牛喜伟,苏碧茹,鲁江,王树堂.中医药对提高非小细胞肺癌中位生存期的作用研究[J].广州中医药大学学报,2005,22(4):255-258. 被引量:50
  • 4Zhang X,Chang A.Somatic mutations of the epidermal growth factor receptor and non small cell lung cancer[J].J Med Genet,2007,44(3):166-172. 被引量:1
  • 5de La Motte Rouge T,Galluzzi L,Olaussen KA,et al.A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell Lung cancer cells resistant to erlotinib[J].Cancer Res,2007,67 (13):6253-6262. 被引量:1
  • 6Niu G,Carter WB.Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways[J].Cancer Res,2007,67(4):1487-1493. 被引量:1
  • 7Sequist LV,Bell DW,Lynch TJ,et al.Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer[J].J Clin Oncol,2007,25 (5):587-595. 被引量:1
  • 8Sheng G,Guo J,Warner BW.Epidermal growth factor receptor signaling modulates apoptosis via p38 MAPK-dependent activation of Bax in intestinal epithelial cells[J].Am J Physiol Gastrointest Liver Physio,2007,293 (3):G599-606. 被引量:1
  • 9Kaulfuss S,Burfeind P,Gaedcke J,et al.Dual silencing of insulin-like growth factor-Ⅰ receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis[J].Mol Cancer Ther,2009,8 (4):821-833. 被引量:1

二级参考文献23

  • 1倪宗瓒.卫生统计学(第4版)[M].北京:人民卫生出版社,2002.84-95. 被引量:9
  • 2周岱翰 张伦 陈锐深.鹤蟾片治疗肺癌临床研究报告[J].新中医,1986,18(4):152-153. 被引量:4
  • 3中华人民共和国医政司.常见恶性肿瘤诊治规范[M].北京:中国协和医科大学出版社,1999.773-781. 被引量:5
  • 4中华人民共和国医政司.常见恶性肿瘤诊治规范[S].北京:中国协和医科大学出版社,1999.773-781. 被引量:12
  • 5Mountain C F. Revisions in the international system for staging lung Cancer [J]. Chest, 1997, 111 (6): 1710. 被引量:1
  • 6Johnson J R, Temple R. Food and Drug Administration requirements for approval of new anti-cancer drugs [J]. Cancer Treat Rep, 1985,69: 1155. 被引量:1
  • 7Fukuoka M, Yano S, Giaccone G, et al. Multi-institutional randomized phase Ⅱ trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancer [ J]. J Clin Oncol, 2003, 21:2237. 被引量:1
  • 8Mountain CF:Revisions in the international system for staging lung cancer.Chest 1997;111(6):1710-1717. 被引量:1
  • 9Patrick Therasse,Susan G,Arbuck,et al.New guidelines to evaluate the response to treatment in solid tumors.J Natl Cancer Inst 2000 ;92(3):205-216. 被引量:1
  • 10吴一龙 廖美琳 蒋国梁 中国抗癌协会肺癌专业委员会.肺癌的诊断治疗临床指引[Z].,2003.60. 被引量:1

共引文献94

同被引文献167

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部